Optomeditech Ltd is an Espoo, Finland-based developer of OptiVein®, a light-guided intravenous catheter system designed to increase first-attempt success in IV cannulation. OptiVein integrates a light guide into the IV catheter needle so tissue illumination helps locate veins and the light disappears when the needle enters the vein, signaling the exact penetration moment. Led by CEO Amiel Rubinstein, the company secured ISO 13485 quality-management certification and a CE mark for OptiVein issued by BSI in the United Kingdom as the notified body. Optomeditech raised $2.5M in funding in a round led by Lifeline Ventures and Sitra, The Finnish Innovation Fund. The product targets the most common invasive procedure in healthcare—IV cannulation—and the certifications support its regulatory compliance for market use.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2014